Patents by Inventor Yves Mory

Yves Mory has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of anti-sense sequences to increase responsiveness to gene amplification
    Patent number: 6399377
    Abstract: A method for regulating the production level of a desired protein in a transformed mammalian cell, comprising: a directly amplifiable gene sequence, in expressable form, which when expressed renders said cell more resistant to a toxic agent; a gene of interest, in expressible form, which encodes a desired protein foreign to said cell; and an anti-sense gene sequence, in transcribable form, encoding an anti-sense RNA capable of selectively hybridizing to at least a portion of the mRNA transcribed from said directly amplifiable gene sequence so as to inhibit the translation of said mRNA, such that a higher level of amplification of said directly amplifiable gene and said gene of interest can be achieved, if the cell is exposed to a sufficient level of the toxic agent, that in the absence of said anti-sense RNA.
    Type: Grant
    Filed: February 3, 1999
    Date of Patent: June 4, 2002
    Inventor: Yves Mory
  • Recombinant production of interferon-gamma binding proteins
    Patent number: 5763210
    Abstract: A cDNA encoding a new interferon-gamma (IFN-.gamma.)-binding protein is disclosed. Methods and products for the recombinant production of the protein are provided, and specific antibodies are also described.
    Type: Grant
    Filed: March 3, 1994
    Date of Patent: June 9, 1998
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Daniela Novick, Yves Mory, Dina G. Fischer, Michel Revel, Menachem Rubinstein
  • IL-6 specific monoclonal antibodies, hybridomas therefor and methods of making and using same
    Patent number: 5618700
    Abstract: The hybridoma 34-1 (CNCM I-813) which produces anti-human IL-6 monoclonal antibody 34-1 is disclosed. Methods of producing the monoclonal antibody and methods for affinity purification of human IL-6 using monoclonal antibody 34-1 are also described.
    Type: Grant
    Filed: November 14, 1989
    Date of Patent: April 8, 1997
    Assignee: Yeda Research & Development Co. Ltd.
    Inventors: Daniela Novick, Michel Revel, Yves Mory, Menachem Rubinstein, Eran Hadas